Overview

Comparative Efficacy and Safety of Two Asparaginase Preparations in Children With Previously Untreated Acute Lymphoblastic Leukaemia

Status:
Completed

Trial end date:
2012-10-01

Target enrollment:

Participant gender:

Summary

This multicentric phase III study is designed to assess the efficacy and safety of recombinant asparaginase (rASNase) in comparison to Asparaginase medac™ during treatment of children with de novo ALL

Phase:

Phase 3

Details

Lead Sponsor:

medac GmbH

Treatments:

Asparaginase